Skip to content

Month: September 2019

ABS’ Sexcel Sexed Genetics Remains on Growth Trajectory After Litigation

DEFOREST, Wis. (Sept. 12, 2019)—ABS Global (ABS), a division of Genus plc, announced today that while disappointed in an unfavorable jury ruling in the patent case between it and ST, ABS remains focused on responding to the increasing demand in the market for Sexcel® sexed genetics. The growth in Sexcel is driven by ABS’ continued…

Read More >